Skip to content

May 4-7, 2020 | Boston, MA

4 days | 4 streams | 6 workshops | 3 seminars | 70+ speakers

AboutMedia Hub

Media Hub

View the latest content of the NASH Summit Boston and other events of the Fibrosis Series

NASH Summit FDA Presentation First Page

An exclusive FDA presentation by:

 

Dr Frank A. Anania, Acting Clinical Team Leader, Division of Gastroenterology and Inborn Error Products, FDA

NASH 2019 - Speaker Interview - Resar Cenar

NASH one pager

Speaker interview-resar cenar
one-pagerr-NASH

Who attended in 2019 

Global Liver Institute, Donna Cryer

whos-attending-3rd NASH snippet
Global Liver Institute

Targeting multiple pathways in NASH - clinical perspectives for combination therapies | Nikolai Naoumov

Molecular MR Imaging of Oxidized Collagen to Monitor Active Fibrogenesis in Preclinical Models of NASH | Bryan Fuchs

Targeting multiple pathways
Molecular MR Imaging

Evaluating Progression Towards Industry Standard In Vitro Models of NAFLD/NASH

In Vitro